📰 Abt News
Page 145 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
June 1, 2023
Arcblock (ABT) traded 0.1% higher against the US dollar during the one day period ending at 22:00 PM Eastern on May 31st. One Arcblock token can currently be purchased for about $0.0947 or 0.00000349 BTC on cryptocurrency exchanges. In the last seven days, Arcblock has traded 0.5% higher against the US dollar. Arcblock has a […]
June 1, 2023
Shares of Abbott Laboratories (NYSE:ABT – Get Rating) have earned a consensus rating of “Moderate Buy” from the twenty-one research firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and ten have given a buy recommendation to the company. […]
June 1, 2023
Haverford Trust Co reduced its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 2.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 87,673 shares of the healthcare product maker’s stock after selling 2,315 shares during the period. Haverford Trust Co’s holdings in […]
June 1, 2023
Credit Suisse AG raised its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 2.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,536,823 shares of the healthcare product maker’s stock after acquiring an additional 70,563 shares during the period. […]
June 1, 2023
Mitchell Capital Management Co. trimmed its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 22.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,173 shares of the healthcare product maker’s stock after selling 4,491 shares during the quarter. Mitchell Capital Management Co.’s holdings […]
June 1, 2023
Tanglewood Legacy Advisors LLC acquired a new position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 875 shares of the healthcare product maker’s stock, valued at approximately $96,000. A number of other hedge funds and other institutional […]
May 31, 2023
Arcblock (ABT) traded 0.7% higher against the dollar during the 1 day period ending at 20:00 PM E.T. on May 30th. Arcblock has a market capitalization of $9.33 million and approximately $280,884.95 worth of Arcblock was traded on exchanges in the last day. One Arcblock token can currently be purchased for about $0.0946 or 0.00000342 […]
May 31, 2023
Cheviot Value Management LLC decreased its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 40.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 18,444 shares of the healthcare product maker’s stock after selling 12,532 shares during the period. Cheviot Value […]
May 31, 2023
Advisory Research Inc. lowered its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 0.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 12,250 shares of the healthcare product maker’s stock after selling 100 shares during the period. Advisory Research Inc.’s holdings in Abbott Laboratories were worth $1,345,000 at the end […]
May 31, 2023
Arcblock (ABT) traded 1.1% higher against the dollar during the 1-day period ending at 15:00 PM Eastern on May 31st. Arcblock has a market cap of $9.38 million and $222,737.61 worth of Arcblock was traded on exchanges in the last 24 hours. One Arcblock token can currently be purchased for approximately $0.0952 or 0.00000352 BTC […]